Your browser doesn't support javascript.
loading
A cutaneous spindle cell neoplasm characterized by a COL3A1::PDGFRA fusion.
Watkins, James; Jackson, Edward; Tarpey, Patrick; Tadross, John A; Trotman, Jamie; O'Dea, Emily.
Afiliação
  • Watkins J; East Genomics Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Jackson E; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Tarpey P; East Genomics Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Tadross JA; East Genomics Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Trotman J; East Genomics Laboratory Hub, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • O'Dea E; MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
J Cutan Pathol ; 2024 May 26.
Article em En | MEDLINE | ID: mdl-38797972
ABSTRACT
Cutaneous spindle cell neoplasms can be challenging to diagnose using routine histopathological techniques alone, and the growing repertoire of molecular studies can assist in diagnosis. We describe a cutaneous spindle cell neoplasm characterized by a COL3A1PDGFRA rearrangement predicted to lead to constitutive activation of the PDGFRA kinase domain. The lesion shows some similarities to dermatofibrosarcoma protuberans and also benign and epithelioid fibrous histiocytomas but is distinct from these entities histopathologically and molecularly. This tumor is considered to represent an entity in the spectrum of PDGFR-driven cutaneous mesenchymal neoplasms.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article